# AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects With Asthma

> **NCT01200108** · PHASE2 · COMPLETED · sponsor: **Activaero GmbH**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Budesonide
- **DRUG:** Budesonide
- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT01200108
- **Lead sponsor:** Activaero GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-10
- **Final completion:** 2011-11
- **Target enrollment:** — (—)
- **Last updated:** 2011-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01200108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01200108, "AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects With Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01200108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*